Exozymes EXOZ Ratios (2023-2026)

NASDAQ EXOZ
$7.38 +0.34 (+4.76%)
As of: Aug 21, 2026 · 3:58 PM EDT
Ratios Dec2023 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Jun2026
Profitability
EBT Margin (Quarter) 150,899.57%
EBIT Margin (Quarter) 140,721.00%
EBITDA Margin (Quarter) 140,721.00%
Operating Margin (Quarter) 140,721.00%
Net Margin (Quarter) 150,899.57%
FCF Margin (Quarter) 127,574.71%
Efficiency
Assets Average (Quarter) 8.30M12.28M10.60M8.70M6.85M6.98M
Invested Capital (Quarter) 0.13M0.12M0.11M0.09M
Leverage & Solvency
Interest Coverage Ratio (Quarter) -3.89-36.10-7.76-8.33-17.65-13.57-30.39-2.64
Times Interest Earned (Quarter) -3.89-36.10-7.76-8.33-17.65-13.57-30.39-2.64
Valuation
Enterprise Value (Quarter) -0.07M-0.23M-9.72M-8.16M-6.99M-5.10M-3.04M-5.65M
Return Ratios
Return on Sales (Quarter) 15.09%
Return on Capital Employed (Quarter) -85.18%-63.44%-86.25%-120.71%-184.08%-200.03%
Return on Assets (Quarter) -0.01%0.00%-0.01%-0.01%-0.01%-0.01%